Phibro Animal Health | 营业费用

金融业

USD

USD 1.41B

现金及等价物

USD 55.49M

USD 207.39M

USD 862.19M

USD 282.37M

USD 474.17M

股息收益率

2.13

USD 26M

USD 30.48M

1.92K

EPS每股收益

USD 0.08

股本和储备

USD 332.36M

USD 101.87M

债务利息支出

USD 8.76M

USD 0.08

USD 603.6M

USD 2.1B

USD 3.19M

USD 332.36M

USD 25.53M

普通股股本

USD 4K

48.92

USD 4.84M

USD 309.26M

销售和管理费用

USD 76.34M

USD 517.35M

贸易债权人

USD 133.3M

应收帐款人

USD 160.78M

	营业费用	更改		日
Align Technology	USD 822.85M		11.8M	2025-12
ANI Pharmaceuticals	USD 505.82M		309.62M	2025-09
Assertio Holdings	USD 105.8M		12.5M	2025-09
Aurora Cannabis	CAD 146.03M		27.79M	2025-09
Bristol-Myers Squibb	USD 8.3B		10.25B	2025-12
Canopy Growth	CAD 80.99M		8.64M	2025-09
Corcept Therapeutics	USD 197.42M		29.66M	2025-09
Eli Lilly	USD 10.31B		1.09B	2025-12
Henry Schein	USD 3.14B		77M	2025-09
Idexx Laboratories	USD 774.97M		24.58M	2025-12
Knight Therapeutics	CAD 89.06M		2.02M	2024-09
Merck	USD 10.16B		558M	2025-12
Nektar Therapeutics	USD 85.09M		109.3M	2025-09
Pacira	USD 166.36M		4.5M	2025-09
Phibro Animal Health	USD 332.36M		20.68M	2025-12
Prestige Brands	USD 200.95M		6.51M	2025-12
Supernus Pharmaceuticals	USD 252.29M		98.98M	2025-09
Zoetis	USD 5.4B		3.94B	2025-09

Phibro Animal Health 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.